Chemical Structure (Gabapentin 01)
Gabapentin Tablet, Coated
Product Images NDC 51224-021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 51224-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tagi Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
This is a chart showing the mean pain score during a 4-week dose titration period and a subsequent 4-week fixed dose period. The chart compares the pain score of those who received a placebo to those who received 3,600 mg/day gabapentin. The chart also includes baseline data and measures taken during 8 different time periods.*
Figure 2 (Gabapentin 03)
Figure 3 (Gabapentin 04)
This appears to be a graph or chart representing the results of two studies. The percentages listed on the left side may indicate effectiveness or efficacy rates. The two studies are labeled "Study 1" and "Study 2". The information in the chart seems to compare two different treatments or medications: "PBO" and "GBP". The numbers "3,600", "1,800", and "2,400" may indicate dosages or quantities of each medication used in the study. Without further context or clearer labeling, it is difficult to provide a more precise description.*
Figure 4 (Gabapentin 05)
Not available. (The text appears to be mostly random characters and does not provide any coherent information.)*
Principal Display Panel (600 mg Tablet Bottle Label)
Each tablet contains 600mg of gabapentin, a medication used to treat seizures and nerve pain. The tablets are film-coated and should be stored at 25°C (77°F). The medication should be dispensed in child-resistant containers with a separate medication guide for each patient.*
Principal Display Panel (800 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
